Bright Minds Biosciences Inc share price logo

Bright Minds Biosciences Inc

NASDAQ: DRUG

Small Cap

$88.90

+2.68

(+3.11%)

as on

Bright Minds Biosciences Inc Stock Performance

as on May 7, 2026 at 6:18 pm IST

  • Day's Low

    Day's High

    $85.94
    $90.00
    downward going graph

    3.33%

    Downside

    1.24%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $23.18
    $123.75
    downward going graph

    73.93%

    Downside

    39.20%

    Upside

    downward going graph

Bright Minds Biosciences Inc share price movements today

Previous Close
$86.22
Open
$87.90
Volume
270.8K
Day's Low - High
$85.94 - $90.00
52 Week Low - High
$23.18 - $123.75

Bright Minds Biosciences Inc Historical Returns

1 Month Return
+ 15.65 %
3 Month Return
+ 17.02 %
1 Year Return
+ 195.35 %
3 Year Return
+ 2944 %
5 Year Return
0 %

Bright Minds Biosciences Inc Stock Fundamentals & Key Indicators

Check Bright Minds Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$843.8M

EPS (TTM)

-6.832

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-26.98%

Bright Minds Biosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bright Minds Biosciences Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$843.8MNANA0.00%
BUY$40.5B130.77%76.3212.55%
BUY$108.5B98.9%25.3835.51%
NA$32.5BNA70.895.37%
BUY$75.6B45.15%17.629.65%

Stock Returns calculator for Bright Minds Biosciences Inc Stock including INR - Dollar returns

The Bright Minds Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Bright Minds Biosciences Inc investment value today

Current value as on today

₹3,31,451

Returns

₹2,31,451

(+231.45%)

Returns from Bright Minds Biosciences Inc Stock

₹1,95,349 (+195.35%)

Dollar Impact

₹36,102 (+36.1%)

Analyst Recommendation on Bright Minds Biosciences Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Bright Minds Biosciences Inc. Average target price of $162.77

Bright Minds Biosciences Inc Share Price Target

Get share price movements and forecasts by analysts on Bright Minds Biosciences Inc.

What analysts predicted

45.38%UPSIDE

Target Price

$162.77

Current Price

$88.9

Analyzed by

7 Analysts

Target

$162.77

Bright Minds Biosciences Inc target price $162.77, a slight upside of 45.38% compared to current price of $88.9. According to 7 analysts rating.

Indian Investors' Interest in Bright Minds Biosciences Inc Stock

Search interest for Bright Minds Biosciences Inc Stock has increased by 45% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:45% versus previous 30 day period

Bright Minds Biosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
-
-
-
0
0
0
Operating Income
-1
-1
0
0
0
-1
-3
-3
-5
-6
EBITDA
-1
-1
0
0
0
-1
-3
-3
-5
-6
Interest Expense
0
0
0
0
-
-
-
-
-
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-1
-1
0
0
0
0
-2
-5
-4
-7
Income Tax Expense
0
0
0
0
-
-
-
-
0
-
Net Income
-1
-1
0
0
0
0
-2
-5
-4
-7
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Bright Minds Biosciences Inc Annual Profit & Loss

All numbers in Millions USD

Sep 2020
Sep 2021
Sep 2022
Sep 2023
Sep 2024
Sep 2025
Total Revenue
-
-
-
-
-
-
Gross Profit
-
-
0
0
-
0
Operating Income
0
-8
-14
-7
-2
-13
EBITDA
0
-8
-14
-7
-2
-13
Interest Expense
-
-
0
0
-
0
Depreciation
-
-
0
0
0
0
Income Before Tax
0
-8
-14
-7
-2
-12
Income Tax Expense
0
0
0
0
-
-
Net Income
0
-6
-11
-5
-2
-12
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Bright Minds Biosciences Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-1
0
0
0
0
-2
-5
-4
-7
Operating Cash Flow
0
0
0
0
-1
-2
-3
-1
-5
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
0
0
0
0
52
0
0
33
13
Change in Cash
0
0
0
0
52
-2
-4
31
6

Bright Minds Biosciences Inc Annual Cash Flow

All numbers in Millions USD

Sep 2020
Sep 2021
Sep 2022
Sep 2023
Sep 2024
Sep 2025
Net Income
0
-8
-14
-7
-2
-12
Operating Cash Flow
0
-7
-13
-7
-1
-8
Investing Cash Flow
-
-
-
-
-
-
Financing Cash Flow
1
26
5
2
0
85
Change in Cash
0
18
-8
-4
-1
77

Global Institutional Holdings in Bright Minds Biosciences Inc

Funds
Holdings
Morgan Stanley - Brokerage Accounts
1.35%
Millennium Management LLC
0.78%
Vanguard Group Inc
0.45%
HHG PLC
11.71%
Longwood Capital Partners LLC
0.86%

Bright Minds Biosciences Inc News & Key Events

  • img

    Today's Timeline - 07 January

    Thu, 08:04 AM

    -

    Bright Minds Biosciences announces pricing of upsized US$175 million public offering at $90.00 per share, closing expected January 9, 2026.

Insights on Bright Minds Biosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, DRUG has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, DRUG stock has moved up by 2944.0%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, DRUG has outperformed top 5 stocks with highest market-cap in its industry

About Bright Minds Biosciences Inc

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatric and neurology indications; and BMB-105, a 5-HT2C agonist to treat Prader Willi Syndrome. Bright Minds Biosciences Inc. has a collaboration with Firefly Neuroscience, Inc. to provide an analysis of the electroencephalogram (EEG) data in the Company's BREAKTHROUGH study. The company was founded in 2017 and is headquartered in New York, New York.
OrganisationBright Minds Biosciences Inc
Headquarters19 Vestry Street, New York, NY, United States, 10013
IndustryBiotechnology
CEOMr. Ian McDonald
E-voting on sharesClick here to vote

Key Management of Bright Minds Biosciences Inc

Name

Title

Mr. Ian McDonald

Co-Founder, CEO, President & Director

Dr. Jan Torleif Pedersen M.Sc., Ph.D.

Chief Science Officer & Director

Mr. Alex Vasilkevich

COO & Senior Scientific Officer

Dr. Emer Leahy M.B.A., Ph.D.

Consultant

Dr. Stephen D. Collins M.D., Ph.D.

Chief Medical Officer

FAQs

What is Bright Minds Biosciences Inc share price today?

Bright Minds Biosciences Inc share price today is $88.9 as on at the close of the market. Bright Minds Biosciences Inc share today touched a day high of $90 and a low of $85.94.

What is the 52 week high and 52 week low for Bright Minds Biosciences Inc share?

Bright Minds Biosciences Inc share touched a 52 week high of $123.75 on and a 52 week low of $23.18 on . Bright Minds Biosciences Inc stock price today i.e. is closed at $88.9,which is 28.16% down from its 52 week high and 283.60% up from its 52 week low.

What is Bright Minds Biosciences Inc's market capitalisation today?

Bright Minds Biosciences Inc market capitalisation is $0.00T as on .

How to invest in Bright Minds Biosciences Inc Stock (DRUG) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bright Minds Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bright Minds Biosciences Inc Shares that will get you 0.0169 shares as per Bright Minds Biosciences Inc share price of $88.9 per share as on May 7, 2026 at 12:48 pm IST.

What is the minimum amount required to buy Bright Minds Biosciences Inc Stock (DRUG) from India?

Indian investors can start investing in Bright Minds Biosciences Inc (DRUG) shares with as little as ₹94.61 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.10 in Bright Minds Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Bright Minds Biosciences Inc share’s latest price of $88.9 as on May 7, 2026 at 12:48 pm IST, you will get 0.1125 shares of Bright Minds Biosciences Inc. Learn more about fractional shares .